Solution for injection – 1000 mg / 10 ml (10 %)

Solution for injection – 85 mg / 10 ml (0.85 %)

Solution for infusion– 0.9%

Solution for infusion– 0.9%

Solution for infusion– 0.9%

Solution for infusion– 0.9%

Solution for infusion– 0.9%

Nasal drops, solution - 0.9 %

 

Solution for infusion– 0.9%

Tablets - 750 000 UI

Spiramicine is a macrolide antibiotic that has similar uses with erythromycin. Macrolides are weak bases; their activity increases at alkaline pH. Macrolides penetrate into the pleural fluid, in the ascitic fluid, in the middle ear exudates and in the sputum. When the meninges are inflamed, they can enter in the cerebrospinal fluid. Macrolides are used in respiratory tract, urogenital, digestive and skin soft tissue infections, especially when beta-lactamic antibiotics or tetracyclines are contraindicated.

Spiramicine is indicated in:

  • the treatment of otorhinolaryngological, bronchopulmonary, stomathological, genital (especially of prostate origin), bone and skin infections;
  • the prophylaxis of meningitis by meningococcus;
  • the cases when rifampicin is contraindicated;
  • the toxoplasmosis of old women.

Tablets - 50 mg

Spirolan contains spironolactone as an active substance which is a diuretic drug (potassium - sparing).

Spirolan is used in:

  • primary hyperaldosteronism (excessive production of a mineralocorticoid, aldosterone), if surgery is not indicated;
  • accumulation of fluid in tissues and / or abdomen (oedema and / or ascites) in diseases associated with secondary hyperaldosteronism.

 

Tablets - 25 mg

Spirolan contains spironolactone as an active substance which is a diuretic drug (potassium - sparing).

Spirolan is used in:

  • primary hyperaldosteronism (excessive production of a mineralocorticoid, aldosterone), if surgery is not indicated;
  • accumulation of fluid in tissues and / or abdomen (oedema and / or ascites) in diseases associated with secondary hyperaldosteronism.

 

Oral suspension - (200 mg + 40 mg/5 ml)

Tablets - 400 mg + 80 mg

Suspension – 40 %

Prolonged-release hard capsules, 0.4 mg

Prolonged-release hard capsules, 0.4 mg

Prostacure is used in the treatment of functional symptoms of benign prostatic hyperplasia, such as difficult urination.

The active ingredient of Prostacure is tamsulosin. Tamsulosin is an alpha-1-receptor blocker which reduces the tension in muscles of prostate and urethra. Thus an easier flow of urine through the urethra and urination are facilitated.

Tablets - 2 mg

 

Tablets - 5 mg

Flotrin Uro contains the active substance terazosin which belongs to a group of medicines (alfa-1-receptor blockers) that relieve the symptoms of benign prostatic hyperplasia and emptying of the bladder.

Flotrin Uro is used for the treatment of:

  • concerns (clinical symptoms)andurinary symptoms associated with benign prostatic hyperplasia (BPH).

Tablets - 250 mg

 

Results 321 - 340 of 377